🚀 VC round data is live in beta, check it out!
Akdital Valuation Multiples
Discover revenue and EBITDA valuation multiples for Akdital and similar public comparables like Pediatrix, Draegerwerk, Surgery Partners, Burjeel Holdings and more.
Akdital Overview
About Akdital
Akdital operates private healthcare clinics. The company offers healthcare services such as cardiac surgery, oncology, radiotherapy, intensive care, and neonatal care, providing patients with comprehensive care according to international standards.
Founded
2016
HQ
Employees
7.1K
Website
Sectors
Financials (LTM)
EV
$2B
Akdital Financials
Akdital reported last 12-month revenue of $555M and EBITDA of $162M.
In the same LTM period, Akdital generated $162M in EBITDA and $54M in net income.
Revenue (LTM)
Akdital P&L
In the most recent fiscal year, Akdital reported revenue of $315M and EBITDA of $93M.
Akdital expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $555M | XXX | $315M | XXX | XXX | XXX |
| Gross Profit | — | XXX | $160M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 51% | XXX | XXX | XXX |
| EBITDA | $162M | XXX | $93M | XXX | XXX | XXX |
| EBITDA Margin | 29% | XXX | 30% | XXX | XXX | XXX |
| EBIT Margin | 19% | XXX | 18% | XXX | XXX | XXX |
| Net Profit | $54M | XXX | $34M | XXX | XXX | XXX |
| Net Margin | 10% | XXX | 11% | XXX | XXX | XXX |
| Net Debt | — | — | $62M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Akdital Stock Performance
Akdital has current market cap of $2B, and enterprise value of $2B.
Market Cap Evolution
Akdital's stock price is $124.44.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $2B | $2B | -3.1% | XXX | XXX | XXX | $2.37 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialAkdital Valuation Multiples
Akdital trades at 3.4x EV/Revenue multiple, and 11.8x EV/EBITDA.
EV / Revenue (LTM)
Akdital Financial Valuation Multiples
As of April 9, 2026, Akdital has market cap of $2B and EV of $2B.
Equity research analysts estimate Akdital's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Akdital has a P/E ratio of 32.8x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $2B | XXX | $2B | XXX | XXX | XXX |
| EV (current) | $2B | XXX | $2B | XXX | XXX | XXX |
| EV/Revenue | 3.4x | XXX | 6.0x | XXX | XXX | XXX |
| EV/EBITDA | 11.8x | XXX | 20.4x | XXX | XXX | XXX |
| EV/EBIT | 18.4x | XXX | 34.4x | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 11.9x | XXX | XXX | XXX |
| P/E | 32.8x | XXX | 52.5x | XXX | XXX | XXX |
| EV/FCF | (8.8x) | XXX | (7.3x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Akdital Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Akdital Margins & Growth Rates
Akdital's revenue in the last 12 month grew by 47%.
Akdital's revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $0.0M for the same period.
Akdital's rule of 40 is 86% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Akdital's rule of X is 172% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Akdital Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 47% | XXX | 52% | XXX | XXX | XXX |
| EBITDA Margin | 29% | XXX | 30% | XXX | XXX | XXX |
| EBITDA Growth | 35% | XXX | 52% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 86% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 172% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.0M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.0M | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 33% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Akdital Public Comps
See public comps and valuation multiples for other Hospitals & Clinics comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Pediatrix | XXX | XXX | XXX | XXX | XXX | XXX |
| Draegerwerk | XXX | XXX | XXX | XXX | XXX | XXX |
| Surgery Partners | XXX | XXX | XXX | XXX | XXX | XXX |
| Burjeel Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
| Select Medical | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Akdital M&A Activity
Akdital acquired XXX companies to date.
Last acquisition by Akdital was on XXXXXXXX, XXXXX. Akdital acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Akdital
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialAkdital Investment Activity
Akdital invested in XXX companies to date.
Akdital made its latest investment on XXXXXXXX, XXXXX. Akdital invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Akdital
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Akdital
| When was Akdital founded? | Akdital was founded in 2016. |
| Where is Akdital headquartered? | Akdital is headquartered in Morocco. |
| How many employees does Akdital have? | As of today, Akdital has over 7K employees. |
| Who is the CEO of Akdital? | Akdital's CEO is Rochdi Talib. |
| Is Akdital publicly listed? | Yes, Akdital is a public company listed on Casablanca Stock Exchange. |
| What is the stock symbol of Akdital? | Akdital trades under AKT ticker. |
| When did Akdital go public? | Akdital went public in 2022. |
| Who are competitors of Akdital? | Akdital main competitors are Pediatrix, Draegerwerk, Surgery Partners, Burjeel Holdings. |
| What is the current market cap of Akdital? | Akdital's current market cap is $2B. |
| What is the current revenue of Akdital? | Akdital's last 12 months revenue is $555M. |
| What is the current revenue growth of Akdital? | Akdital revenue growth (NTM/LTM) is 47%. |
| What is the current EV/Revenue multiple of Akdital? | Current revenue multiple of Akdital is 3.4x. |
| Is Akdital profitable? | Yes, Akdital is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Akdital? | Akdital's last 12 months EBITDA is $162M. |
| What is Akdital's EBITDA margin? | Akdital's last 12 months EBITDA margin is 29%. |
| What is the current EV/EBITDA multiple of Akdital? | Current EBITDA multiple of Akdital is 11.8x. |
| What is the current FCF of Akdital? | Akdital's last 12 months FCF is ($216M). |
| What is Akdital's FCF margin? | Akdital's last 12 months FCF margin is (39%). |
| What is the current EV/FCF multiple of Akdital? | Current FCF multiple of Akdital is (8.8x). |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.